EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,861,835 | +2535.4% | 608,490 | +2769.6% | 0.00% | – |
| Q2 2023 | $184,484 | +197.6% | 21,205 | +1.6% | 0.00% | – |
| Q1 2023 | $62,000 | +112627.3% | 20,868 | +33.3% | 0.00% | – |
| Q4 2022 | $55 | -100.0% | 15,651 | -5.0% | 0.00% | – |
| Q3 2022 | $131,000 | +7.4% | 16,480 | +6.7% | 0.00% | – |
| Q2 2022 | $122,000 | -36.1% | 15,447 | -1.8% | 0.00% | – |
| Q1 2022 | $191,000 | +40.4% | 15,730 | +41.1% | 0.00% | – |
| Q4 2021 | $136,000 | +58.1% | 11,152 | +36.6% | 0.00% | – |
| Q3 2021 | $86,000 | -69.4% | 8,164 | -73.8% | 0.00% | – |
| Q2 2021 | $281,000 | +28000.0% | 31,218 | +25915.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 120 | +500.0% | 0.00% | – |
| Q4 2020 | $0 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |